NCT04257708

Brief Summary

Uterine cavity evaluation is an integral part of assessment Of women for ICSI

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2020

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 4, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 6, 2020

Completed
3 days until next milestone

Study Start

First participant enrolled

February 9, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 10, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2021

Completed
Last Updated

February 6, 2020

Status Verified

February 1, 2020

Enrollment Period

9 months

First QC Date

February 4, 2020

Last Update Submit

February 4, 2020

Conditions

Infertility

Outcome Measures

Primary Outcomes (1)

  • The number of women who will has positive pregnancy test

    The women who will got pregnant

    within a year

Study Arms (2)

normal uterine cavity

Diagnostic Test: ultrasound

abnormal uterine cavity

Diagnostic Test: ultrasound

Interventions

ultrasoundDIAGNOSTIC_TEST

Transvaginal us to assess the cavity

abnormal uterine cavitynormal uterine cavity

Eligibility Criteria

Age18 Years - 42 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsInfertile women
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Women with infertility

You may qualify if:

  • women with infertility more than one year

You may not qualify if:

  • omen with medical disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Algazeerah

Giza, Egypt

Location

MeSH Terms

Conditions

Infertility

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Genital DiseasesUrogenital Diseases

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Mahmoud Alalfy, PhD

    Algezeera

    STUDY CHAIR

Central Study Contacts

Mahmoud Alalfy

CONTACT

01002611058mahmoudalalfy@ymail.com

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2020

First Posted

February 6, 2020

Study Start

February 9, 2020

Primary Completion

November 10, 2020

Study Completion

January 10, 2021

Last Updated

February 6, 2020

Record last verified: 2020-02

Locations

EG(1)